Home LiteratureArticle Details
PMID: 10348780 Published · ppublish English Journal Article

Rifampin and rifabutin resistance mechanism in Helicobacter pylori.

Antimicrobial agents and chemotherapy ·Vol. 43 ·No. 6 ·1999-06-00 ·Pages 1497-9

Heep M, Beck D, Bayerdörffer E, Lehn N

Abstract

Eighty-one clinical isolates of Helicobacter pylori showed no resistance to rifampin (MIC range, 0.032 to 2 microg/ml; MIC at which 50% of isolates are inhibited [MIC50], 0.25 microg/ml). The MIC50 of rifabutin was 0.008 microg/ml (n = 16). All resistant laboratory mutants of H. pylori ATCC 43504 showed amino acid exchanges in codons 524 to 545 or codon 585 of the rpoB gene, corresponding to the gene sequences from Mycobacterium tuberculosis and Escherichia coli.

MeSH Terms
Amino Acid Sequence Anti-Bacterial Agents/pharmacology Codon Helicobacter pylori/drug effects,genetics Humans Microbial Sensitivity Tests Molecular Sequence Data Rifabutin/pharmacology Rifampin/pharmacology
Chemicals
Anti-Bacterial Agents Codon Rifabutin Rifampin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Heep M
Institut für Medizinische Mikrobiologie, Universitätsklinikum Regensburg, D-93053, Regensburg, Germany. Markus.Heep@klinik.uni-regensburg.de
Beck D
Bayerdörffer E
Lehn N
References (12)
12 references, click to expand
  1. Rifampicin resistance in Neisseria meningitidis: evidence from a study of sibling strains, description of new mutations and notes on population genetics.
    J Antimicrob Chemother. 1997 Jun;39(6):747-55 PMID: 9222044
  2. The complete genome sequence of the gastric pathogen Helicobacter pylori.
    Nature. 1997 Aug 7;388(6642):539-47 PMID: 9252185
  3. Molecular evolution of rifampicin resistance in Streptococcus pneumoniae.
    Microb Drug Resist. 1998 Spring;4(1):65-70 PMID: 9533728
  4. Treatment of antibiotic-resistant Helicobacter pylori.
    N Engl J Med. 1998 Jul 2;339(1):53 PMID: 9660694
  5. Rifampicin region revisited. New rifampicin-resistant and streptolydigin-resistant mutants in the beta subunit of Escherichia coli RNA polymerase.
    J Biol Chem. 1993 Jul 15;268(20):14820-5 PMID: 8325861
  6. Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 1998 Jul;42(7):1853-7 PMID: 9661035
  7. Antimicrobial activity of rifabutin.
    Clin Infect Dis. 1996 Apr;22 Suppl 1:S3-13; discussion S13-4 PMID: 8785253
  8. Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan.
    Antimicrob Agents Chemother. 1996 Apr;40(4):1053-6 PMID: 8849230
  9. Rifampin resistance in Neisseria meningitidis due to alterations in membrane permeability.
    Antimicrob Agents Chemother. 1996 Mar;40(3):646-51 PMID: 8851587
  10. A mechanism of rifamycin inhibition and resistance in Pseudomonas aeruginosa.
    J Antimicrob Chemother. 1996 Jul;38(1):133-7 PMID: 8858465
  11. Detection of point mutations in rpoB gene of rifampin-resistant Rickettsia typhi.
    Antimicrob Agents Chemother. 1998 Jul;42(7):1845-6 PMID: 9661032
  12. RNA polymerase (rpoB) mutants selected for increased resistance to gyrase inhibitors in Salmonella typhimurium.
    Mol Gen Genet. 1995 Jun 25;247(6):680-92 PMID: 7616959
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1999-06-00
Pages
1497-9
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC89306
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com